Japan achieves heart stem cell transplant
Japan has successfully performed the first transplant of heart muscle cell sheets derived from induced pluripotent stem cells (iPS) to treat patients with ischemic heart disease. During the procedure, which lasted an hour at Osaka Kasatsu Hospital, new cells were implanted into the heart of a woman in her fifties, aiming to support and improve the function of her heart muscle. This is considered the first clinical treatment of its kind and seeks to enhance the quality of life for patients suffering from heart muscle damage, especially those who have exhausted other treatment options. The medical team plans to conduct similar procedures on around 75 patients by 2033 to further evaluate effectiveness and safety on a broader scale. The technique relies on reprogramming mature cells into a state similar to stem cells, opening new horizons for the treatment of damaged tissues and organs, and is currently one of the most prominent fields in regenerative medicine.
Notice: This Is an AI-Generated Summary
Comments (0)